Form D · Biotechnology

Precision Biologics, Inc.

Rockville, MD · CIK 0001560075

Offering snapshot reported Oct 19, 2015 · SEC filing

Reported sold
$53.1M
Offering amount: $53.1M
Investors reported
34
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Oct 2, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 19, 2015Initial$53,096,422No comparison34SEC filing
Apr 2, 2014Initial$795,000No comparison11SEC filing
Dec 16, 2013Initial$10,500,000No comparison14SEC filing
May 21, 2013Initial$2,192,885No comparison85SEC filing
May 21, 2013Amendment$3,289,327$1,096,442vs May 21, 201385SEC filing
Oct 11, 2012Initial$5,313,075No comparison30SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-249681

Source: Form D, filed Oct 19, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stanley B. Archibald, Jr. Director, Promoter
Philip M. Arlen Director, Executive
R.J. Childress Executive
C. Brent Haggard Director
Charles Kim Director
Mark Kristen Director
Albine K Martin Executive
Sheldon Rabin Director
Severin Russo Director
Patrick Soon Shiong Director
Robert A Washington Executive
Christian Zapf Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11300 Rockville Pike Suite 1140
Rockville, MD, 20852